Featured Research

from universities, journals, and other organizations

Prescribing antipsychotics in combination with other psychotropic medications becoming more common in youth, study shows

Date:
June 25, 2014
Source:
Children's Hospital of Philadelphia
Summary:
An increase in the concurrent prescribing of second-generation antipsychotics (SGA) – typically used to treat severe mental disorders – with other psychotropic medications among Medicaid-enrolled youth has been identified in a new study. Researchers say the data is a rich resource for providing a picture of clinical practice trends on a national scale and can valuable in informing policies and practice around SGA use.

A national study conducted by researchers at The Children's Hospital of Philadelphia's PolicyLab shows an increase in the concurrent prescribing of second-generation antipsychotics (SGA) -- one type of medication used for the treatment of severe mental disorders such as schizophrenia and mania -- with other psychotropic medications among Medicaid-enrolled youth. The study, published online on June 23rd in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), found that while overall SGA use increased by 22 percent from 2004 to 2008, the majority (85 percent) of youth using SGA were prescribed this medication concurrently with another psychotropic medication class.

This large-scale, population-based study, using a data set estimating medication use for 10.6 million children annually, is a rich resource for providing a picture of clinical practice trends on a national scale and can be valuable in informing policies and practice around SGA use.

The researchers used national Medicaid data from the Centers for Medicare and Medicaid Services, for years 2004, 2006, and 2008, to calculate the number of youth who received SGA concurrently with each of the four most commonly prescribed psychotropic medication classes (stimulants, antidepressants, mood stabilizers, and alpha agonists). They also calculated the average annual number of days each psychotropic medication class was prescribed and the days of concurrent SGA use.

Concurrent SGA use increased over time. Notably, by 2008, 1 in 5 stimulant users also received SGA, as well as 1 in 3 antidepressant users. The researchers note that for youth prescribed SGA alongside other psychotropic medications, the concurrent use was present for an average of four to five months in a given year, suggesting the addition of SGA was intended for long-term use rather than as a short-term strategy for behavioral health crisis situations.

"We knew that antipsychotic use was increasing among youth, but we were surprised to learn just how often youth on common psychotropic medications like stimulants or antidepressants also receive an antipsychotic as part of their treatment, and when they do, it is for sustained periods of time," said David M. Rubin, MD, MSCE, a senior author of the study, attending pediatrician, and co-director of CHOP's PolicyLab.

While the rates of concurrent SGA use were 30-60 percent higher among youth in foster care and youth with disability-related Medicaid eligibility, the growth in concurrent SGA use over time was largest among income-eligible youth, who represent the majority of youth served by the Medicaid program. Additionally, youth with ADHD experienced disproportionate increases in concurrent SGA prescribing over time, including youth with a sole diagnosis of ADHD, who experienced a 15 percent increase over the time period.

"The numbers tell a story of emerging clinical practice, where concurrent antipsychotic use by youth is no longer on the margins; rather, we are seeing a shift in use toward less-impaired groups of youth, including among those with ADHD and no other behavioral health diagnosis and among those who were never hospitalized," explained Rubin.

"It is also noteworthy that the largest growth within the Medicaid program has not been among populations with high clinical need in the foster care and disability programs, but rather among those with income eligibility for Medicaid. This article foretells the spread of this therapy into general psychiatric practice," said Rubin.

Growing evidence of serious metabolic side effects of SGAs in youth, including weight gain and diabetes, heightens concern for the use of concurrent SGA.

"The reality is that there is very little safety and efficacy data for SGA in most youth, and we must also consider potential drug-drug interactions when SGAs are used concurrently with other medications," explained Amanda Kreider, the study's lead author and a researcher at PolicyLab. "As clinical practice moves toward the prescribing of these medication combinations in youth with less severe psychiatric impairments, consideration of alternative, non-pharmacologic interventions and, at minimum, monitoring of potential side effects will be critical."


Story Source:

The above story is based on materials provided by Children's Hospital of Philadelphia. Note: Materials may be edited for content and length.


Journal Reference:

  1. Amanda R. Kreider, Meredith Matone, Christopher Bellonci, Susan dosReis, Chris Feudtner, Yuan-Shung Huang, David M. Rubin. Growth in the Concurrent Use of Antipsychotics With Other Psychotropic Medications in Medicaid-Enrolled Children. Journal of the American Academy of Child & Adolescent Psychiatry, 2014; DOI: 10.1016/j.jaac.2014.05.010

Cite This Page:

Children's Hospital of Philadelphia. "Prescribing antipsychotics in combination with other psychotropic medications becoming more common in youth, study shows." ScienceDaily. ScienceDaily, 25 June 2014. <www.sciencedaily.com/releases/2014/06/140625151233.htm>.
Children's Hospital of Philadelphia. (2014, June 25). Prescribing antipsychotics in combination with other psychotropic medications becoming more common in youth, study shows. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2014/06/140625151233.htm
Children's Hospital of Philadelphia. "Prescribing antipsychotics in combination with other psychotropic medications becoming more common in youth, study shows." ScienceDaily. www.sciencedaily.com/releases/2014/06/140625151233.htm (accessed July 28, 2014).

Share This




More Mind & Brain News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Losing Sleep Leaves You Vulnerable To 'False Memories'

Losing Sleep Leaves You Vulnerable To 'False Memories'

Newsy (July 27, 2014) A new study shows sleep deprivation can make it harder for people to remember specific details of an event. Video provided by Newsy
Powered by NewsLook.com
University Quiz Implies Atheists Are Smarter Than Christians

University Quiz Implies Atheists Are Smarter Than Christians

Newsy (July 25, 2014) An online quiz from a required course at Ohio State is making waves for suggesting atheists are inherently smarter than Christians. Video provided by Newsy
Powered by NewsLook.com
Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins